Decoy Therapeutics Inc.
DCOY· Nasdaq
DCOYDecoy Therapeutics Inc.
Filed Nov 2, 2016 · 10-Q · 33 days after period end · 0001615219-16-000226
| Metric | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|
| Revenue | $599.07K | $0.00 | — |
| Net Income | -$10.64M | -$8.15M | -$1.99M |
| EPS Diluted | -$0.65 | -$0.53 | -$1.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Decoy Therapeutics Inc. · CIK 1615219 · Engraved from SEC EDGAR
ended Sep 30, 2016 · filed Nov 2, 2016 · 33 d after period end
